Stay updated with breaking news from Bed Availability. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The positivity rate in the national capital stands at 2.52 per cent. On April 22, the city had recorded its highest positivity rate of 36.2 per cent. The Delhi government had launched the dedicated COVID-19 helpline number 1031 to provide information to residents about the availability of beds in hospitals, oxygen cylinders and medicines etc.
Updated: May 20, 2021 11:36 IST ‘It is unfortunate that people are spreading unverified information, which will affect COVID-19 positive patients who are on the lookout for beds or admission in the CCC,’ says a doctor. Share Article AAA BBMP yet to utilise beds in the Covid care centre created at Koramangala indoor stadium, in Bengaluru on May 08, 2021. | Photo Credit: MURALI KUMAR K ‘It is unfortunate that people are spreading unverified information, which will affect COVID-19 positive patients who are on the lookout for beds or admission in the CCC,’ says a doctor. While the pri...
“While last year we lost nearly 730 doctors across India, this year in a short period of time we have lost 244 doctors. The second wave is proving extremely fatal for all and especially those at the forefront of the battle. We have to actively increase vaccination cover among the medical staff to ensure that they have protection against the virus,’’ said IMA president J.A. Jayalal. The following are the figures of fatalities according to the IMA registry: Andhra Pradesh (21), Telangana (19), Maharashtra (13), Tamil Nadu (10), Karnataka and Odisha (8 each), Madhya Pradesh (5), Chhattisga...
Updated: Developed with DRL, it reduces oxygen-dependence in patients Share Article AAA Defence Minister Rajnath Singh hands over the first batch of 2-DG anti Covid drug to the Union Health Minister Harsh Vardhan, in New Delhi on May 17, 2021. Photo: Twitter/@rajnathsingh Developed with DRL, it reduces oxygen-dependence in patients The first batch of the adjunct COVID therapy drug, 2-deoxy-D-glucose (2-DG) — developed by the Defence Research and Development Organisation (DRDO) along with Dr Reddy’s Laboratories (DRL), Hyderabad — was on Monday released for emergency use. Defence M...
The second consignment reportedly comprises 60,000 doses, a confirmation on which is awaited from Dr. Reddy’s Laboratories.